Azole Antifungal Resistance in Candida albicans and Emerging Non- albicans Candida Species

Within the limited antifungal armamentarium, the azole antifungals are the most frequent class used to treat infections. Azole antifungals such as fluconazole are often preferred treatment for many infections as they are inexpensive, exhibit limited toxicity, and are available for oral administratio...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in microbiology 2017-01, Vol.7, p.2173-2173
Main Authors: Whaley, Sarah G, Berkow, Elizabeth L, Rybak, Jeffrey M, Nishimoto, Andrew T, Barker, Katherine S, Rogers, P David
Format: Article
Language:English
Subjects:
Microbiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Within the limited antifungal armamentarium, the azole antifungals are the most frequent class used to treat infections. Azole antifungals such as fluconazole are often preferred treatment for many infections as they are inexpensive, exhibit limited toxicity, and are available for oral administration. There is, however, extensive documentation of intrinsic and developed resistance to azole antifungals among several species. As the frequency of azole resistant isolates in the clinical setting increases, it is essential to elucidate the mechanisms of such resistance in order to both preserve and improve upon the azole class of antifungals for the treatment of infections. This review examines azole resistance in infections caused by as well as the emerging non- species , and and in particular, describes the current understanding of molecular basis of azole resistance in these fungal species.
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2016.02173